Patent Law Weblog
recent posts
- Retired Judges File Amicus Brief in Support of Judge Newman
- Hikma v. Amarin at the Supreme Court: The Parties’ Opening Briefs
- Teva Pharmaceuticals International v. Eli Lilly & Co. (Fed. Cir. 2026)
- USPTO Extends Artificial Intelligence Search Automated Pilot Program (ASAP!)
- USPTO Announces That It Has Turned the Corner on Unexamined Application Backlog
about
Month: September 2012
-
Technology Transfer Tactics will be offering a webinar entitled "Myriad: The Gene Patent Fight Continues . . ." on October 4, 2012 from 1:00 – 2:00 pm (Eastern). Patent Docs author Dr. Kevin Noonan of McDonnell, Boehnen, Hulbert & Berghoff LLP will analyze the most recent decision in the AMP v. USPTO case and discuss…
-
American Conference Institute (ACI) will be holding a conference on Orphan Drugs and Rare Diseases: Maximizing Opportunities and Overcoming Stumbling Blocks in the Designation and Development Process on November 28-29, 2012 in Boston, MA. The conference will allow attendees to: • Understand and comply with the FDA's current regulations and policies to gauge the legitimate…
-
By Donald Zuhn — On Wednesday, the U.S. Patent and Trademark Office published a notice in the Federal Register (77 Fed. Reg. 54360) issuing a final rule regarding the adjustment of certain patent fee amounts for fiscal year 2013 to reflect fluctuations in the Consumer Price Index (CPI). Pursuant to 35 U.S.C. § 41(f), the…
-
By Donald Zuhn — USPTO Seeks Comments on Proposed Fee Schedule Yesterday, the U.S. Patent and Trademark Office announced that it would be publishing a notice in the Federal Register on September 6, 2012, seeking public input on proposed patent fees. The Office noted that: The proposed fees are at least 22 percent lower for…
-
On 8 October 2011, the Court of Justice of the European Union's (CJEU) handed down a landmark judgment on the correct interpretation of Article 6(2)(c) of the Biotechnology Directive (98/44/EC) relating to the patentability of human embryonic stem cells. The Court of Justice's judgment The decision excludes an invention from patentability where the technical teaching…
-
By Kevin E. Noonan — Last Friday, the Federal Circuit reconsidered en banc the Court's decisions in Akamai Technologies, Inc. v. Limelight Networks, Inc. and McKesson Technologies, Inc. v. Epic Systems Corp. Long awaited, the decision was handed down "per curiam," with a majority consisting of Chief Judge Rader joined by Judges Lourie, Bryson, Moore,…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. GlaxoSmithKline LLC v. Apotex Inc.1:12-cv-01090; filed August 31, 2012 Infringement of U.S. Patent Nos. 5,565,467 ("Androstenone Derivative," issued October 15, 1996) following a Paragraph IV certification as part of Apotex's filing of an ANDA to…
-
September 5, 2012 – Inter Partes Review: Rules and Strategy (Intellectual Property Owners Association ) – 2:00 – 3:00 pm September 6, 2012 – A Review of the Impact of Recent Supreme Court and Federal Circuit Decisions on Patent Strategy (McDonnell Boehnen Hulbert & Berghoff LLP) – 10:00 – 11:15 am (CT) September 9-11, 2012…
-
The American Intellectual Property Law Association (AIPLA) will be holding its 2012 annual meeting on October 25-27, 2012 in Washington, DC. Among the sessions being offered during the annual meeting will be: Plenary Session — The Impact of the AIA Rules Concurrent Track — Patent Litigation Under the AIA — including presentations on: • AIA…
Patent Docs 